Who Paid My Doc
Menopur
Drug Reproductive Health
NDC 55566-7501-2
General payments
$1,774,860
Research payments
$9,642,219
Through program year 2023, $1,774,860 in general payments and $9,642,219 in research payments were reported against Menopur (Reproductive Health).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $657,471 | 3,829 |
| 2023 | Research | $740,494 | 20 |
| 2022 | General | $756,794 | 3,751 |
| 2022 | Research | $69,742 | 75 |
| 2021 | General | $99,573 | 2,768 |
| 2021 | Research | $3,770,214 | 221 |
| 2020 | General | $120,035 | 1,872 |
| 2020 | Research | $3,851,168 | 196 |
| 2019 | General | $140,987 | 3,825 |
| 2019 | Research | $1,210,602 | 20 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.
The top 5 of 42 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 49 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
16,045 general · 532 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.